Item 2.02 Results of Operations and Financial Condition.

On August 5, 2021, Magenta Therapeutics, Inc. (the "Company") announced its financial results for the quarter ended June 30, 2021. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangements of Certain

Officers.

On August 3, 2021, Michael W. Bonney notified the Company of his intent to resign from the Company's Board of Directors (the "Board") and its committees effective August 3, 2021, to focus on his newly expanded role as Executive Chair of Alnylam Pharmaceuticals, Inc. Mr. Bonney's decision to resign from the Board was not the result of any dispute or disagreement with the Company or the Board on any matter relating to the Company's operations, policies, or practices.

In connection with Mr. Bonney's resignation, effective August 4, 2021, the size of the Board was reduced from ten members to nine members, Alison F. Lawton, currently a member of the Board, was appointed Chair of the Board, and Jeffrey W. Albers, also a current member of the Board, was appointed to the Board's audit committee.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:



The following exhibit relating to Item 2.02 shall be deemed furnished, and not
filed:



99.1      Press Release dated August 5, 2021.

104     Cover Page Interactive Data File (embedded within the Inline XBRL document).




                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses